1263 related articles for article (PubMed ID: 19699866)
1. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
[TBL] [Abstract][Full Text] [Related]
2. B-type natriuretic peptide-guided heart failure therapy: A meta-analysis.
Porapakkham P; Porapakkham P; Zimmet H; Billah B; Krum H
Arch Intern Med; 2010 Mar; 170(6):507-14. PubMed ID: 20308637
[TBL] [Abstract][Full Text] [Related]
3. B-type natriuretic peptide in heart failure.
Moe GW
Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
[TBL] [Abstract][Full Text] [Related]
4. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.
Berger R; Moertl D; Peter S; Ahmadi R; Huelsmann M; Yamuti S; Wagner B; Pacher R
J Am Coll Cardiol; 2010 Feb; 55(7):645-53. PubMed ID: 20170790
[TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial.
Lainchbury JG; Troughton RW; Strangman KM; Frampton CM; Pilbrow A; Yandle TG; Hamid AK; Nicholls MG; Richards AM
J Am Coll Cardiol; 2009 Dec; 55(1):53-60. PubMed ID: 20117364
[TBL] [Abstract][Full Text] [Related]
6. N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.
Rutten JH; Steyerberg EW; Boomsma F; van Saase JL; Deckers JW; Hoogsteden HC; Lindemans J; van den Meiracker AH
Am Heart J; 2008 Jul; 156(1):71-7. PubMed ID: 18585499
[TBL] [Abstract][Full Text] [Related]
7. The role of natriuretic peptide testing in guiding chronic heart failure management: review of available data and recommendations for use.
Januzzi JL
Arch Cardiovasc Dis; 2012 Jan; 105(1):40-50. PubMed ID: 22369917
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis.
Ryding AD; Kumar S; Worthington AM; Burgess D
Anesthesiology; 2009 Aug; 111(2):311-9. PubMed ID: 19602961
[TBL] [Abstract][Full Text] [Related]
9. Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers.
George J; Patal S; Wexler D; Abashidze A; Shmilovich H; Barak T; Sheps D; Keren G
Arch Intern Med; 2005 Jun; 165(11):1304-9. PubMed ID: 15956012
[TBL] [Abstract][Full Text] [Related]
10. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
[TBL] [Abstract][Full Text] [Related]
11. Rapid Emergency Department Heart Failure Outpatients Trial (REDHOT II): a randomized controlled trial of the effect of serial B-type natriuretic peptide testing on patient management.
Singer AJ; Birkhahn RH; Guss D; Chandra A; Miller CD; Tiffany B; Levy P; Dunne R; Bastani A; Thode HC; Hollander JE
Circ Heart Fail; 2009 Jul; 2(4):287-93. PubMed ID: 19808351
[TBL] [Abstract][Full Text] [Related]
12. Serial monitoring of brain natriuretic peptide concentrations for drug therapy management in patients with chronic heart failure.
Gallegos PJ; Maclaughlin EJ; Haase KK
Pharmacotherapy; 2008 Mar; 28(3):343-55. PubMed ID: 18294114
[TBL] [Abstract][Full Text] [Related]
13. B-type natriuretic peptide-guided chronic heart failure therapy: a meta-analysis of 11 randomised controlled trials.
Li P; Luo Y; Chen YM
Heart Lung Circ; 2013 Oct; 22(10):852-60. PubMed ID: 23602555
[TBL] [Abstract][Full Text] [Related]
14. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
Green SM; Green JA; Januzzi JL
Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
[TBL] [Abstract][Full Text] [Related]
15. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results.
Wu AH
Am Heart J; 2006 Nov; 152(5):828-34. PubMed ID: 17070141
[TBL] [Abstract][Full Text] [Related]
16. BNP in the diagnosis and risk stratification of heart failure.
Moe GW
Heart Fail Monit; 2005; 4(4):116-22. PubMed ID: 16234898
[TBL] [Abstract][Full Text] [Related]
17. Health gains by using natriuretic peptides in diagnosis, prognosis and treatment.
Richards M; Troughton R; Lainchbury J; Doughty R; Wright S
Scand J Clin Lab Invest Suppl; 2005; 240():129-37. PubMed ID: 16112970
[TBL] [Abstract][Full Text] [Related]
18. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.
Miller WL; Hartman KA; Burritt MF; Grill DE; Rodeheffer RJ; Burnett JC; Jaffe AS
Circulation; 2007 Jul; 116(3):249-57. PubMed ID: 17592074
[TBL] [Abstract][Full Text] [Related]
19. Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure.
Davis ME; Richards AM; Nicholls MG; Yandle TG; Frampton CM; Troughton RW
Circulation; 2006 Feb; 113(7):977-85. PubMed ID: 16476851
[TBL] [Abstract][Full Text] [Related]
20. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM
J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
